David Sherwood
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
David Sherwood has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
- Byron J. Schneider
Department of Physical Medicine and Rehabilitation, Vanderbilt University Medical Center, Nashville, TN, USA
6 shared publications Adam Epps
Department of Physical Medicine and Rehabilitation, Vanderbilt University Medical Center , Nashville, Tennessee
4 shared publicationsMichael Modic
Department of Radiology Vanderbilt University Medical Center Nashville Tennessee USA
3 shared publicationsBenjamin Gill
Department of Physical Medicine and Rehabilitation, University of Missouri, Columbia , Columbia, Missouri
2 shared publications- Dann Martin
Dept of Radiology, Vanderbilt University Medical Center, Nashville, USA
2 shared publications Evan Berlin
2 shared publications
Latest Publications
- 14 September 2026
- Published by Wolters Kluwer Health in American Journal of Physical Medicine & Rehabilitation
Clinical Practice Audit of 60-day Temporary Peripheral Nerve Stimulation
Objective: To prospectively evaluate pain relief and functional outcomes through 14 months after 60-day percutaneous peripheral nerve stimulation (PNS) in a consecutive real-world cohort. Design: Prospective single-center observational cohort study of 102 consecutive patients implanted with 60-day temporary percutaneous PNS for chronic pain. Outcomes were collected at 2 weeks and 2, 5, 8, 11, and 14 months. The principal outcome measure was the proportion reporting ≥50% pain relief at each follow-up interval. Secondary outcomes included ≥80% pain relief, numeric pain rating scale (NRS), Brief Pain Inventory item 9a (BP-9a), Oswestry Disability Index, Patient Global Impression of Change (PGIC), and adverse events. Results: ≥50% pain relief was reported by 49/102 (48.0%; 95% CI, 38.0–58.2%) at 2 weeks, 34/102 (33.3%; 95% CI, 24.3–43.4%) at 2 months, 16/102 (15.7%; 95% CI, 9.2–24.2%) at 5 months, 10/102 (9.8%; 95% CI, 4.8–17.3%) at 8 months, and 4/102 (3.9%; 95% CI, 1.1–9.7%) at 11 months. At 14 months, no participants met the ≥50% threshold (0/4 observed case; 0/102 under the fixed-denominator framework). Conclusions: In this heterogeneous real-world cohort, 60-day temporary PNS produced short-term benefit in a subset of patients, but durable post-explant response was uncommon.
- 14 September 2026
- Published by Wolters Kluwer Health in American Journal of Physical Medicine & Rehabilitation
Clinical Practice Audit of 60-day Temporary Peripheral Nerve Stimulation
Objective: To prospectively evaluate pain relief and functional outcomes through 14 months after 60-day percutaneous peripheral nerve stimulation (PNS) in a consecutive real-world cohort. Design: Prospective single-center observational cohort study of 102 consecutive patients implanted with 60-day temporary percutaneous PNS for chronic pain. Outcomes were collected at 2 weeks and 2, 5, 8, 11, and 14 months. The principal outcome measure was the proportion reporting ≥50% pain relief at each follow-up interval. Secondary outcomes included ≥80% pain relief, numeric pain rating scale (NRS), Brief Pain Inventory item 9a (BP-9a), Oswestry Disability Index, Patient Global Impression of Change (PGIC), and adverse events. Results: ≥50% pain relief was reported by 49/102 (48.0%; 95% CI, 38.0–58.2%) at 2 weeks, 34/102 (33.3%; 95% CI, 24.3–43.4%) at 2 months, 16/102 (15.7%; 95% CI, 9.2–24.2%) at 5 months, 10/102 (9.8%; 95% CI, 4.8–17.3%) at 8 months, and 4/102 (3.9%; 95% CI, 1.1–9.7%) at 11 months. At 14 months, no participants met the ≥50% threshold (0/4 observed case; 0/102 under the fixed-denominator framework). Conclusions: In this heterogeneous real-world cohort, 60-day temporary PNS produced short-term benefit in a subset of patients, but durable post-explant response was uncommon.
- Open Access
- 25 August 2026
- Published by Elsevier in Interventional Pain Medicine
- Vol. 5 (3)
Prolonged response following anesthetic-only medial branch blocks: A retrospective analysis of 410 consecutive procedures
- 25 August 2026
- Published by Elsevier in Interventional Pain Medicine
- Vol. 5 (3)
Open AccessProlonged response following anesthetic-only medial branch blocks: A retrospective analysis of 410 consecutive procedures
- Open Access
- 13 February 2026
- Published by Elsevier in Interventional Pain Medicine
- Vol. 5 (1) , 100741
Insurance directed conservative care for low back pain: A prospective observational study
- 13 February 2026
- Published by Elsevier in Interventional Pain Medicine
- Vol. 5 (1) , 100741
Open AccessInsurance directed conservative care for low back pain: A prospective observational study
- Open Access
- 5 June 2024
- Published by Elsevier in North American Spine Society Journal (NASSJ)
- Vol. 19, 100334
The association between preoperative epidural steroid injections and postoperative cervical and lumbar surgical site infections: A systematic review and meta-analysis
- 5 June 2024
- Published by Elsevier in North American Spine Society Journal (NASSJ)
- Vol. 19, 100334
Open AccessThe association between preoperative epidural steroid injections and postoperative cervical and lumbar surgical site infections: A systematic review and meta-analysis
- Open Access
- 2 June 2023
- Published by Oxford University Press (OUP) in Pain Medicine
- Vol. 24 (10) , 1131-1132
Treating refractory posterior sacroiliac joint complex pain in the current healthcare ecosystem: a call to action
David Sherwood, DO, Aaron Yang, MD, Christine Hunt, DO, David Provenzano, MD, Lynn Kohan, MD, Robert W Hurley, MD PhD, Steven P Cohen, MD, Vinil Shah, MD, Zacha
- 2 June 2023
- Published by Oxford University Press (OUP) in Pain Medicine
- Vol. 24 (10) , 1131-1132
Open AccessTreating refractory posterior sacroiliac joint complex pain in the current healthcare ecosystem: a call to action
David Sherwood, DO, Aaron Yang, MD, Christine Hunt, DO, David Provenzano, MD, Lynn Kohan, MD, Robert W Hurley, MD PhD, Steven P Cohen, MD, Vinil Shah, MD, Zacha
- Open Access
- 17 March 2023
- Published by Elsevier in Interventional Pain Medicine
- Vol. 2 (1)
Commentary on recent spinal cord stimulation publications
- 17 March 2023
- Published by Elsevier in Interventional Pain Medicine
- Vol. 2 (1)
Open AccessCommentary on recent spinal cord stimulation publications
- 18 October 2022
- Published by Wiley in Journal of Orthopaedic Research
- Vol. 41 (5) , 1123-1130
The interrater reliability of Modic changes among a potential basivertebral nerve ablation population: Why AC1 may be preferred to kappa
Interrater reliability of Modic changes is subject to variables which affect consistency in reporting. Given the importance of Modic change identification for basivertebral nerve ablation (BVNA) candidacy, interrater reliability for this specific cohort has not yet been reported. Twenty lumbar magnetic resonance images of potential basivertebral nerve candidates were independently reviewed by two neuroradiologists and two interventional spine physiatrists for the presence and characterization of Modic changes. The kappa value of their agreement on the presence of Modic changes was 0.52 (95% confidence interval [CI] 0.37–0.67), whereas agreement on the type of Modic change was 0.51 (95% CI 0.37–0.65). Using an alternative methodology for measuring interrater reliability (Gwet's AC1) yielded the identification of the presence of Modic changes at AC1 0.51 (95% CI 0.36–0.66), whereas agreement on the type of Modic change was AC1 0.75 (95% CI 0.66–0.83). While less common, AC1 may be preferred in the appropriate cohort to kappa as it mitigates some of the pitfalls to which kappa values may be victim. Ultimately, our results are in‐line with previous reports of interrater reliability results for Modic changes in other cohorts and should serve to caution those who perform BVNA regarding interrater agreement of the imaging crux of the procedure.
- 18 October 2022
- Published by Wiley in Journal of Orthopaedic Research
- Vol. 41 (5) , 1123-1130
The interrater reliability of Modic changes among a potential basivertebral nerve ablation population: Why AC1 may be preferred to kappa
Interrater reliability of Modic changes is subject to variables which affect consistency in reporting. Given the importance of Modic change identification for basivertebral nerve ablation (BVNA) candidacy, interrater reliability for this specific cohort has not yet been reported. Twenty lumbar magnetic resonance images of potential basivertebral nerve candidates were independently reviewed by two neuroradiologists and two interventional spine physiatrists for the presence and characterization of Modic changes. The kappa value of their agreement on the presence of Modic changes was 0.52 (95% confidence interval [CI] 0.37–0.67), whereas agreement on the type of Modic change was 0.51 (95% CI 0.37–0.65). Using an alternative methodology for measuring interrater reliability (Gwet's AC1) yielded the identification of the presence of Modic changes at AC1 0.51 (95% CI 0.36–0.66), whereas agreement on the type of Modic change was AC1 0.75 (95% CI 0.66–0.83). While less common, AC1 may be preferred in the appropriate cohort to kappa as it mitigates some of the pitfalls to which kappa values may be victim. Ultimately, our results are in‐line with previous reports of interrater reliability results for Modic changes in other cohorts and should serve to caution those who perform BVNA regarding interrater agreement of the imaging crux of the procedure.
- 2 June 2022
- Published by Oxford University Press (OUP) in Pain Medicine
- Vol. 23 (11) , 1858-1862
A First Estimate of the Annual Prevalence of Basivertebral Nerve Ablation Candidates in a Spine Clinic
Background: Emerging literature supports the use of basivertebral nerve ablation (BVNA) for a specific cohort of patients with chronic low back pain and Type 1 or Type 2 Modic changes from vertebral levels L3–S1. The early literature warrants further evaluation. Studies establishing the efficacy of BVNA use highly selective patient criteria. Objective: Provide a first estimate of the prevalence of BVNA candidates in a spine clinic over a year using the foundational studies patient selection criteria? Methods: A retrospective review of four fellowhsip trained spine physiatrists patient encounters at a large academic medical center using relevant ICD-10 codes to isolate chronic low back pain without radiating symptoms from January 1, 2019 to January 1, 2020. Charts were then reviewed by a team of physicians for exclusionary criteria from the foundational studies which have demonstrated benefit from BVNA. MRI’s from qualifying charts which did not meet exclusionary criteria were then independently reviewed by four physician for localization and characterization of Modic changes. Results: The relevant diagnostic codes query yielded 338 unique patient records. Based on exclusionary criteria or lack of imaging availability, 318 charts were eliminated. The remaining 20 charts qualified for imaging review. There were 11 charts in which there was 100% agreement between all reviewers regarding the presence and either Type 1 or Type 2 Modic changes between vertebral levels L3 to S1. Accordingly, the prevalence of eligibility for BVNA was 3% (11/338, 95% CI 1–5%). Conclusion: The population which may benefit from BVNA is small. Our study demonstrated that over a year, the prevalence for BVNA candidacy using the foundational studies criteria was 3% (95% CI 1% – 5%). While physicians may be tempted to use less stringent selection criteria in practice, upon doing so they cannot cite the foundational studies as evidence for the outcomes they expect to achieve. Those outcomes will require more studies which formally assess the benefits of BVNA when selection criteria are relaxed.
- 2 June 2022
- Published by Oxford University Press (OUP) in Pain Medicine
- Vol. 23 (11) , 1858-1862
A First Estimate of the Annual Prevalence of Basivertebral Nerve Ablation Candidates in a Spine Clinic
Background: Emerging literature supports the use of basivertebral nerve ablation (BVNA) for a specific cohort of patients with chronic low back pain and Type 1 or Type 2 Modic changes from vertebral levels L3–S1. The early literature warrants further evaluation. Studies establishing the efficacy of BVNA use highly selective patient criteria. Objective: Provide a first estimate of the prevalence of BVNA candidates in a spine clinic over a year using the foundational studies patient selection criteria? Methods: A retrospective review of four fellowhsip trained spine physiatrists patient encounters at a large academic medical center using relevant ICD-10 codes to isolate chronic low back pain without radiating symptoms from January 1, 2019 to January 1, 2020. Charts were then reviewed by a team of physicians for exclusionary criteria from the foundational studies which have demonstrated benefit from BVNA. MRI’s from qualifying charts which did not meet exclusionary criteria were then independently reviewed by four physician for localization and characterization of Modic changes. Results: The relevant diagnostic codes query yielded 338 unique patient records. Based on exclusionary criteria or lack of imaging availability, 318 charts were eliminated. The remaining 20 charts qualified for imaging review. There were 11 charts in which there was 100% agreement between all reviewers regarding the presence and either Type 1 or Type 2 Modic changes between vertebral levels L3 to S1. Accordingly, the prevalence of eligibility for BVNA was 3% (11/338, 95% CI 1–5%). Conclusion: The population which may benefit from BVNA is small. Our study demonstrated that over a year, the prevalence for BVNA candidacy using the foundational studies criteria was 3% (95% CI 1% – 5%). While physicians may be tempted to use less stringent selection criteria in practice, upon doing so they cannot cite the foundational studies as evidence for the outcomes they expect to achieve. Those outcomes will require more studies which formally assess the benefits of BVNA when selection criteria are relaxed.
- Open Access
- 26 April 2022
- Published by Elsevier in Interventional Pain Medicine
- Vol. 1 (2)
The interrater reliability of the novel Udby classification of Modic Changes: A first estimate
- 26 April 2022
- Published by Elsevier in Interventional Pain Medicine
- Vol. 1 (2)
Open AccessThe interrater reliability of the novel Udby classification of Modic Changes: A first estimate
- Open Access
- 6 January 2022
- Published by Elsevier in Interventional Pain Medicine
- Vol. 1 (1)
Lumbar medial branch block progression to radiofrequency neurotomy: A retrospective audit of clinical practice
- 6 January 2022
- Published by Elsevier in Interventional Pain Medicine
- Vol. 1 (1)
Open AccessLumbar medial branch block progression to radiofrequency neurotomy: A retrospective audit of clinical practice